GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » Piotroski F-Score

Indegene (NSE:INDGN) Piotroski F-Score : 5 (As of Mar. 14, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Indegene has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Indegene's Piotroski F-Score or its related term are showing as below:

NSE:INDGN' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 5
Current: 5

During the past 4 years, the highest Piotroski F-Score of Indegene was 5. The lowest was 4. And the median was 5.


Indegene Piotroski F-Score Historical Data

The historical data trend for Indegene's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Piotroski F-Score Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Piotroski F-Score
N/A N/A 4.00 5.00

Indegene Quarterly Data
Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 5.00 - - -

Competitive Comparison of Indegene's Piotroski F-Score

For the Health Information Services subindustry, Indegene's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indegene's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indegene's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Indegene's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was ₹3,367 Mil.
Cash Flow from Operations was ₹5,077 Mil.
Revenue was ₹25,896 Mil.
Gross Profit was ₹25,896 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was (22038.66 + 25456) / 2 = ₹23747.33 Mil.
Total Assets at the begining of this year (Mar23) was ₹22,039 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3,986 Mil.
Total Current Assets was ₹17,908 Mil.
Total Current Liabilities was ₹6,109 Mil.
Net Income was ₹2,661 Mil.

Revenue was ₹23,061 Mil.
Gross Profit was ₹23,061 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was (13534.69 + 22038.66) / 2 = ₹17786.675 Mil.
Total Assets at the begining of last year (Mar22) was ₹13,535 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4,795 Mil.
Total Current Assets was ₹14,487 Mil.
Total Current Liabilities was ₹4,891 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Indegene's current Net Income (TTM) was 3,367. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Indegene's current Cash Flow from Operations (TTM) was 5,077. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=3367/22038.66
=0.15277698

ROA (Last Year)=Net Income/Total Assets (Mar22)
=2661/13534.69
=0.19660591

Indegene's return on assets of this year was 0.15277698. Indegene's return on assets of last year was 0.19660591. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Indegene's current Net Income (TTM) was 3,367. Indegene's current Cash Flow from Operations (TTM) was 5,077. ==> 5,077 > 3,367 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3986/23747.33
=0.16785045

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=4795.37/17786.675
=0.26960463

Indegene's gearing of this year was 0.16785045. Indegene's gearing of last year was 0.26960463. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=17908/6109
=2.93141267

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=14487.06/4891.46
=2.96170469

Indegene's current ratio of this year was 2.93141267. Indegene's current ratio of last year was 2.96170469. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Indegene's number of shares in issue this year was 238.896. Indegene's number of shares in issue last year was 239.269. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=25896/25896
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=23061/23061
=1

Indegene's gross margin of this year was 1. Indegene's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=25896/22038.66
=1.17502607

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=23061/13534.69
=1.70384397

Indegene's asset turnover of this year was 1.17502607. Indegene's asset turnover of last year was 1.70384397. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Indegene has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Indegene  (NSE:INDGN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Indegene Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Indegene's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines